MPX International Corp. (MPXOF)
MPX International Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $14,432. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of -369.4%. Its beta of -0.99 implies it has historically moved less than the broad market.
MPX International Corporation operates as a cannabis enterprise, concentrating its efforts on both the medicinal and recreational cannabis sectors across Canada and Switzerland. The company manufactures and supplies a trio of product categories, encompassing raw cannabis flower, various cannabis extracts and related items, and cannabis derivatives, all marketed under its Strain Rec and Salus BioPharma labels. Established in 2015, the firm's corporate headquarters are situated in Toronto, Canada.
MPX International Corp. is most often compared with the following Healthcare names: